Loading ANIP total return...
Loading summary...

About ANIP Dividend Returns

ANI Pharmaceuticals, Inc. (ANIP) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ANIP over the past year?

ANI Pharmaceuticals, Inc. (ANIP) delivered a total return of 19.62% over the past year when dividends are reinvested. The price-only return was 19.62%, meaning dividends contributed an additional 0.00 percentage points to total returns.

Q2How much would $10,000 invested in ANIP be worth today?

A $10,000 investment in ANI Pharmaceuticals, Inc. one year ago would be worth $11,962 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $11,962. Dividend reinvestment added $0 to the portfolio value.

Q3Does ANIP pay dividends?

Yes, ANI Pharmaceuticals, Inc. (ANIP) pays dividends. In the last year, ANIP paid approximately $0.05 per share in dividends (0.06% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.

Q4Did ANIP beat the S&P 500?

No, ANI Pharmaceuticals, Inc. (ANIP) underperformed the S&P 500 by 11.70 percentage points over the past year. ANIP delivered a total return of 19.62%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed ANIP by 11.70pp during this period.

Q5What is ANIP's worst drawdown?

ANI Pharmaceuticals, Inc. (ANIP) experienced a maximum drawdown of -28.66% over the past year, declining from its peak on 2025-09-15 to its trough on 2026-03-13. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ANIP's long-term total return over 10, 20, or 30 years?

Here are ANI Pharmaceuticals, Inc. (ANIP)'s long-term returns with dividends reinvested. Over 10 years, the total return is 80.8% (6.1% CAGR) — $10,000 would have grown to $18,081. Over 20 years: -43.9% total return (-2.8% CAGR) — $10,000 → $5,613. Over 30 years: -60.7% total return (-3.1% CAGR) — $10,000 → $3,933. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ANIP's best and worst year?

ANI Pharmaceuticals, Inc.'s best calendar year was 2014 with a total return of 192.6%. Its worst year was 2008 with a total return of -72.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 265.2 percentage points.

💰

Find the Best Dividend Stocks

Screen for dividend stocks with the highest total returns (including DRIP).

View Dividend Stocks →

Compare Similar Stocks

Deep Dive into ANIP